#healthcare

Boehringer Ingelheim’s drug, survodutide, has shown promising results in a mid-stage clinical trial for treating metabolic dysfunction-associated steatohepatitis (MASH) in patients with fatty liver disease. The drug demonstrated significant improvements in liver fibrosis without any safety issues. The drug, developed in collaboration with Zealand Pharma, targets gut hormone receptors to decrease appetite and increase energy…

DiaCarta has partnered with OncoAssure to validate and commercialize OncoAssure’s prostate test, which helps identify patients at lower risk of prostate cancer recurrence. The test assesses the risk of aggressive disease post-diagnosis and biochemical recurrence post-surgery. DiaCarta’s expertise in clinical diagnostic services will aid in completing the Laboratory Developed Test validation for the prostate test….

Daewoong Pharmaceutical has launched an AI-driven drug development system called DAVID, consisting of an 800 million-compound database for discovering new drugs. The system includes AIVS for uncovering active substances and Daisy for predicting drug properties, leading to the discovery of weight loss, diabetes, and cancer treatments. By shortening the drug development process, Daewoong aims to…

California Governor Gavin Newsom is pushing Proposition 1, a $6.4 billion bond that aims to address the state’s homelessness crisis. The proposition would fund new housing units and treatment beds for the homeless, in addition to altering how existing tax funding for mental health services is spent. Despite increased homelessness statistics, Newsom’s investments have placed…

A study published in The Journal of Clinical Endocrinology & Metabolism found that adults with type 1 diabetes who have higher insulin sensitivity, as measured by estimated glucose disposal rate (eGDR), are more likely to have better glycemic control. Researchers examined data from 335 adults with type 1 diabetes and found that those with higher…

Survodutide, a drug developed by Boehringer Ingelheim and Zealand Pharma, showed success in treating a serious liver condition called MASH in a Phase 2 study. The drug resulted in significant improvements in 83% of patients compared to 18% in the placebo group without worsening fibrosis. Zealand Pharma’s stock price doubled over the past year due…

The World Health Organization (WHO) published new infection prevention and control (IPC) guidelines for Ebola and Marburg disease in August 2023, replacing previous guidelines issued in 2014 and 2016. The updated guidelines focus on engineering and administrative controls over personal protective equipment (PPE) and emphasize the need for strong evidence to support IPC recommendations. The…

A study published in Nature Cell Biology explores the role of β-cells in the onset of type 1 diabetes (T1D), shedding light on the mechanisms involved. Researchers have identified a signaling pathway controlling the immune response in β-cells and found that enhancing levels of the enzyme METTL3 can delay disease progression in a mouse model…

The study “The Well-Being of Women in Healthcare Professions: A Comprehensive Review” explores factors affecting the well-being of female healthcare professionals. It highlights the importance of addressing work-related stressors and promoting a supportive work environment to prevent burnout and improve job satisfaction. Factors such as work-life balance, personal relationships, gender bias, lifestyle interventions, and professional…

Idiopathic hypersomnia (IH) is a sleep disorder with no cure, causing excessive sleepiness. It can affect daily life and work or school performance. Treatment options may include medication, therapy, and lifestyle changes. People with IH may need more than 11 hours of sleep each night and may benefit from making sleep a priority. Behavioral therapy,…